Instalab
logoInstalab

CAC Score PDA

See exactly which artery on your heart is hardening, not just whether your overall calcium total is high.

Should you take a CAC Score PDA test?

This test is most useful if any of these apply to you.

Mapping Where Your Plaque Lives
If you already had a calcium scan and want to know which arteries are driving your total score, the per-vessel breakdown shows you exactly where.
Family History of Heart Disease
If a parent or sibling had an early heart attack or stent, this scan can reveal whether silent plaque is already taking hold in your own arteries.
On a Statin and Tracking Response
If you take a statin and want to monitor how your plaque is evolving, vessel-specific scoring gives a more detailed view of the change over time.
Healthy but Want to Stay Ahead
If your standard labs look fine but you want to know whether silent atherosclerosis is already underway, this is the most direct look without a contrast scan.

About CAC Score PDA

When you get a coronary calcium scan, the radiologist does not just hand you a single total number. The scan breaks calcified plaque down by individual artery, and this score reports how much hardened plaque sits in the posterior descending artery, a vessel that runs along the back of your heart and supplies blood to a large portion of the lower wall and the heart's electrical system. Knowing where your plaque lives, not just how much you have, gives you a more precise read on where atherosclerosis is taking hold.

This is a per-vessel breakdown of the broader coronary artery calcium (CAC) score, a test that has become one of the most reliable predictors of heart attack and cardiovascular death in people without symptoms. Most published research reports the total CAC score rather than a vessel-specific number, so the PDA component is best used as part of the full per-vessel picture alongside the left main, left anterior descending, circumflex, and right coronary scores.

What This Number Actually Measures

PDA stands for posterior descending artery. In most people, it branches off the right coronary artery, and in a smaller share, it branches off the circumflex. The test counts how much calcium has accumulated inside that specific vessel, reported in Agatston units. Calcified plaque forms when long-running irritation of the artery wall triggers smooth muscle cells to behave like bone-building cells, depositing calcium into the plaque. The score reflects how long, and how aggressively, that process has been happening in this particular artery.

A higher number in the posterior descending artery means more hardened plaque sits there. A score of zero means the scan did not detect any calcified plaque in that vessel, though it does not rule out softer, non-calcified plaque that calcium scoring cannot see.

Why Total Calcium Matters, and What Your PDA Score Contributes

The overwhelming majority of evidence linking coronary calcium to outcomes uses the total score across all arteries. In a meta-analysis of about 34,000 symptomatic patients, higher total calcium scores were strongly tied to a higher rate of major heart events. In an analysis of 6,814 adults followed for ten years through the Multi-Ethnic Study of Atherosclerosis, total CAC strongly predicted heart attack and cardiovascular death regardless of age, sex, or ethnicity.

Your PDA score contributes to that total. A high PDA score with low scores elsewhere tells a different story than calcium spread evenly across every vessel. Research has not produced standardized cutpoints for individual artery scores, so the PDA reading is most useful as one piece of the full breakdown, not a number to interpret in isolation.

Heart Attack and Stroke Risk

Studies on total CAC, which includes the PDA component, give the clearest read on risk. In a study of 4,948 adults in the multinational CONFIRM registry, people with a total CAC score above 300 had a rate of major heart events similar to people who had already been diagnosed with cardiovascular disease. In a follow-up of 66,636 asymptomatic adults from the CAC Consortium, those with total scores of 1,000 or higher had substantially elevated risk of cardiovascular death, cancer death, and death from any cause compared with people in the 400 to 999 range.

In younger adults, the story is similar. A study of 13,397 adults under 50 found that any detectable coronary calcium raised long-term risk of heart attack and stroke, and severe calcification pushed risk of death noticeably higher. These findings come from total CAC, not the posterior descending artery score specifically, but the PDA contributes to the total.

Mortality and Long-Term Outcomes

A retrospective study of 4,529 adults linked higher total CAC scores to higher rates of death from any cause, an association that was especially strong in people under 65. A systematic review combining low-dose CT lung cancer screening data also found that incidentally detected coronary calcium predicted cardiovascular death in current and former smokers.

Kidney Disease

Calcium in the coronary arteries is not only a downstream marker of heart disease. In a study of 113,171 younger and middle-aged adults, higher total CAC scores predicted future chronic kidney disease, even at low calcium levels. In 1,579 adults already living with chronic kidney disease (the KNOW-CKD cohort), total CAC independently predicted heart events and death.

Reference Ranges

There are no standardized clinical cutpoints for the posterior descending artery score on its own. The ranges below come from the broader CAC literature, which reports total scores across all arteries. Use these as orientation for understanding the magnitude of your PDA number in the context of your total score, not as targets specific to one vessel. Your radiologist's report will compare your numbers across vessels and against age, sex, and sometimes ethnicity-specific percentiles.

Total CAC TierAgatston ScoreWhat It Suggests
Zero0No detectable calcified plaque, very low short-term event risk in asymptomatic adults
Mild1 to 99Some atherosclerosis present, modestly elevated risk that warrants attention to standard risk factors
Moderate100 to 299Substantial plaque burden, risk comparable to needing primary prevention therapy in most cases
High300 or higherRisk approaching that of people with established cardiovascular disease per CONFIRM registry analysis

These tiers are drawn from total CAC literature, not the posterior descending artery score specifically. Lab-to-lab variation in CT protocols can shift individual numbers, so the most useful comparisons happen within the same scanner and the same reading method over time.

Tracking Your Trend

A single calcium scan is a snapshot. Calcified plaque does not disappear, so a once-and-done view of your PDA score tells you what has built up over decades, not what is happening now. The more useful question is whether your number is growing slowly, holding steady relative to age expectations, or progressing fast. Repeated CT scans show how plaque is moving and whether your prevention plan is keeping pace.

Interscan variability is real. A classic study of 120 patients found that repeated electron-beam CT measurements varied by about 19.9 percent using traditional Agatston scoring. Treat changes smaller than roughly 15 to 20 percent with caution, especially for low absolute scores where a small absolute change can look like a big percent change.

A reasonable cadence: get a baseline scan, repeat in 3 to 5 years if you are actively managing risk factors and starting from a low or moderate score, and sooner if you are starting therapy and want to gauge response. Radiation exposure is low but not zero, so you do not want to repeat every year without reason.

When Results Can Be Misleading

A few situations can distort a single reading or change how you should interpret it:

  • Coronary dominance: in roughly 10 to 15 percent of people, the posterior descending artery branches from the circumflex or from both vessels rather than the right coronary artery. A small or zero PDA score in this group may simply reflect anatomy, not lower risk.
  • Statin therapy: statins can increase calcified plaque even as they lower heart attack risk. A rising PDA score on a statin does not mean your medication is failing.
  • Scanner and protocol variation: different CT machines and reading methods produce somewhat different numbers. Try to repeat scans on the same equipment when possible.
  • Soft plaque blind spot: calcium scoring cannot see non-calcified plaque, which is often the more rupture-prone type. A low PDA score does not mean the artery is free of disease, especially in younger adults.

Reading a Counterintuitive Finding

Statins increase calcium scores but reduce heart attacks, which sounds like a contradiction. The resolution: not all plaque carries equal risk. Soft, non-calcified plaque is more likely to rupture and cause a heart attack. Statins appear to push soft plaque toward a denser, more stable, calcified form. So a rising calcium number on statins, in the posterior descending artery or elsewhere, can reflect plaque stabilization rather than disease progression. This is why doctors interpret serial CAC scores differently in people on statins than in people who are not.

What to Do If Your PDA Score Is Elevated

An elevated number in the posterior descending artery, especially alongside elevated scores in other vessels, is a signal to act on cardiovascular risk factors aggressively. Concrete next steps:

  • Get the full lipid picture: order ApoB (apolipoprotein B, a count of all plaque-building cholesterol particles) and Lp(a) (lipoprotein little a, an inherited risk factor that standard cholesterol panels miss).
  • Check inflammation: hs-CRP (high-sensitivity C-reactive protein, a marker of low-grade inflammation linked to plaque progression) adds context to your risk picture.
  • Assess insulin and glucose health: HbA1c (a three-month average of blood sugar), fasting insulin, and a glucose reading help reveal whether metabolic issues are feeding plaque growth.
  • Talk to a preventive cardiologist or lipidologist: especially if your total score is above 100 or if you have a family history of premature heart disease, a specialist can help calibrate intensity of lipid-lowering and other therapies.

A high CAC score is one of the strongest signals that intensive prevention is worth the effort. A meta-analysis of intervention studies found that a non-zero score significantly raises the likelihood that people start and stay on statins, aspirin, and lifestyle changes. The number is most useful when it changes what you do.

What Moves This Biomarker

Evidence-backed interventions that affect your CAC Score PDA level

Increase
Take a statin
Statins raise your calcium score even while lowering your heart attack risk, because they convert softer, rupture-prone plaque into denser, more stable calcified plaque. In a large CAC Consortium analysis of 280,525 adults, statin users had higher calcium scores than non-users, yet the score still predicted risk and statin therapy independently reduced events. A rising number on a statin is not a sign the medication is failing. Evidence is for total CAC, not the posterior descending artery score specifically.
MedicationModerate Evidence
Decrease
Add a PCSK9 inhibitor (alirocumab) to statin therapy
Adding alirocumab (a medication that helps the liver clear LDL cholesterol from the blood) on top of statins slowed coronary calcification progression in a randomized trial of patients with coronary artery disease. This is helpful for people whose LDL remains high despite a statin. Evidence is for total CAC, not the posterior descending artery score specifically.
MedicationModerate Evidence
Decrease
Take icosapent ethyl (purified EPA omega-3)
Icosapent ethyl added to statin therapy slowed coronary plaque progression in the EVAPORATE trial of 80 patients with elevated triglycerides. The biggest effect was on softer, low-attenuation plaque, but progression of total and calcified plaque was also slowed compared with placebo. This is the same medication shown to reduce heart attack and stroke risk in REDUCE-IT. Evidence is for CT angiography findings, not the posterior descending artery calcium score specifically.
SupplementModerate Evidence
Decrease
Build cardiorespiratory fitness
In a study of 241 adults with coronary artery disease, higher exercise capacity, but not omega-3 fatty acid consumption, predicted lower coronary calcium scores in both men and women. Evidence is for total CAC, not the posterior descending artery score specifically.
ExerciseModerate Evidence
Decrease
Follow a DASH (Dietary Approaches to Stop Hypertension) eating pattern
In the MASALA cohort of South Asians living in America, adherence to the DASH diet was associated with about 41 percent lower odds of coronary artery calcification, particularly in men. A separate meta-analysis of prospective cohorts linked DASH adherence to lower risk of coronary artery disease overall. Evidence is for total CAC, not the posterior descending artery score specifically.
DietModerate Evidence
Decrease
Take aged garlic extract
Aged garlic extract slowed coronary calcification progression in randomized trials, including a study of 104 adults at increased cardiovascular risk and earlier trials in firefighters and statin-treated patients. The effect on the posterior descending artery specifically has not been reported.
SupplementModest Evidence
Decrease
Take vitamin K2 supplementation
A meta-analysis of randomized trials suggested vitamin K supplementation may slow coronary artery calcification progression and reduce a related marker of calcification activity. The evidence is preliminary and the authors called for more rigorous trials. Evidence is for total CAC, not the posterior descending artery score specifically.
SupplementModest Evidence
Decrease
Follow a Mediterranean-style eating pattern
In a study of 1,255 US adults, higher Mediterranean diet scores were tied to lower volumes of pericardial fat (fat surrounding the heart) and lower cardiovascular risk markers. Higher fruit, vegetable, and Mediterranean adherence have been linked to lower risk of calcium progression in systematic reviews. Evidence is for total CAC and related cardiac measures, not the posterior descending artery score specifically.
DietModest Evidence

Frequently Asked Questions

References

26 studies
  1. Elnagar B, Habib M, Elnagar R, Khalfallah MBMC Cardiovascular Disorders2024
  2. Lo-kioeng-shioe MS, Rijlaarsdam-hermsen D, Van Domburg RV, Hadamitzky M, Lima J, Hoeks S, Deckers JInternational Journal of Cardiology2020
  3. Budoff M, Young RL, Burke G, Carr JJ, Detrano R, Folsom a, Kronmal R, Lima J, Liu K, Mcclelland R, Michos E, Post W, Shea S, Watson K, Wong NEuropean Heart Journal2018
  4. Peng AW, Mirbolouk M, Orimoloye OA, Osei a, Dardari Z, Dzaye O, Budoff M, Shaw L, Miedema M, Rumberger J, Berman D, Rozanski a, Al-mallah M, Nasir K, Blaha MJACC Cardiovascular Imaging2019